secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gossamer Bio, Inc. (GOSS)
CIK:        0001728117
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001728117-23-000081
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gossamer Bio shareholders approve officer liability amendment, re-elect directors at annual meeting
--------------------------------------------------------------------------------

- Amendment to eliminate officer liability for monetary damages passed with 55.97M for, 2.92M against, effective June 8, 2023.
- Directors Faheem Hasnain and Russell Cox re-elected as Class II directors for three-year terms.
- Ernst & Young LLP ratified as independent auditor for FY 2023 with 76.28M for, 72,683 against.
- Say-on-pay advisory vote on named executive officer compensation passed with 38.90M for, 19.98M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728117/000172811723000081/0001728117-23-000081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728117/000172811723000081/goss-20230608.htm
  HTML page:      https://secwatch.observer/filing/0001728117-23-000081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer